BioCentury | Jun 15, 2015
Finance

Deerfield pays Tribute to Pozen

...said Karnal. "We've worked with Adrian and Andrew through their previous companies including Kos, Inspire, Sepracor...
BioCentury | Aug 11, 2014
Company News

Bial-Portela, moksha8 deal

...Aptiom . Sumitomo gained U.S. and Canadian rights to Zebinix through its 2009 acquisition of Sepracor Inc....
BioCentury | Jul 28, 2014
Clinical News

Aptiom eslicarbazepine acetate regulatory update

...November. Dainippon gained U.S. and Canadian rights to the product through its 2009 acquisition of Sepracor Inc....
BioCentury | May 26, 2014
Clinical News

Zebinix eslicarbazepine acetate regulatory update

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Apr 14, 2014
Company News

Dainippon Sumitomo sales and marketing update

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Feb 10, 2014
Clinical News

Zebinix eslicarbazepine acetate regulatory update

...treat epilepsy. Dainippon gained U.S. and Canadian rights to Aptiom through its 2009 acquisition of Sepracor Inc....
BioCentury | Jan 20, 2014
Clinical News

Aptiom eslicarbazepine acetate: Additional Phase III data

...treat epilepsy. Dainippon gained U.S. and Canadian rights to Aptiom through its 2009 acquisition of Sepracor Inc....
BioCentury | Nov 11, 2013
Clinical News

Aptiom eslicarbazepine acetate regulatory update

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Nov 9, 2013
Company News

FDA approves Dainippon's Aptiom for seizures

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Nov 4, 2013
Clinical News

Zebinix eslicarbazepine acetate regulatory update

...gained rights to the voltage-gated sodium and T-type calcium channel blocker through its acquisition of Sepracor Inc....
Items per page:
1 - 10 of 725
BioCentury | Jun 15, 2015
Finance

Deerfield pays Tribute to Pozen

...said Karnal. "We've worked with Adrian and Andrew through their previous companies including Kos, Inspire, Sepracor...
BioCentury | Aug 11, 2014
Company News

Bial-Portela, moksha8 deal

...Aptiom . Sumitomo gained U.S. and Canadian rights to Zebinix through its 2009 acquisition of Sepracor Inc....
BioCentury | Jul 28, 2014
Clinical News

Aptiom eslicarbazepine acetate regulatory update

...November. Dainippon gained U.S. and Canadian rights to the product through its 2009 acquisition of Sepracor Inc....
BioCentury | May 26, 2014
Clinical News

Zebinix eslicarbazepine acetate regulatory update

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Apr 14, 2014
Company News

Dainippon Sumitomo sales and marketing update

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Feb 10, 2014
Clinical News

Zebinix eslicarbazepine acetate regulatory update

...treat epilepsy. Dainippon gained U.S. and Canadian rights to Aptiom through its 2009 acquisition of Sepracor Inc....
BioCentury | Jan 20, 2014
Clinical News

Aptiom eslicarbazepine acetate: Additional Phase III data

...treat epilepsy. Dainippon gained U.S. and Canadian rights to Aptiom through its 2009 acquisition of Sepracor Inc....
BioCentury | Nov 11, 2013
Clinical News

Aptiom eslicarbazepine acetate regulatory update

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Nov 9, 2013
Company News

FDA approves Dainippon's Aptiom for seizures

...rights to the voltage-gated sodium and T-type calcium channel blocker through its 2009 acquisition of Sepracor Inc....
BioCentury | Nov 4, 2013
Clinical News

Zebinix eslicarbazepine acetate regulatory update

...gained rights to the voltage-gated sodium and T-type calcium channel blocker through its acquisition of Sepracor Inc....
Items per page:
1 - 10 of 725